Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)
Go back to Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.28 +0.53 (3.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.75 | 52 Week High | $19.75 | |||
| Open | $13.78 | 52 Week Low | $4.26 | |||
| Day High | $14.40 | P/E | N/A | |||
| Day Low | $13.70 | EPS | $0.00 | |||
| Volume | 7,392,225 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.65 +0.12 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.53 | 52 Week High | $63.73 | |||
| Open | $17.82 | 52 Week Low | $8.00 | |||
| Day High | $18.18 | P/E | N/A | |||
| Day Low | $17.50 | EPS | $-5.69 | |||
| Volume | 2,354,968 | |||||
